LIGAND PHARMACEUTICALS INC cotiza a 300.61 USD y tiene una capitalización bursátil de $6.0B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunog…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $2.37 | $1.63 | $2.02 |
| Estimado | $2.31 | $1.95 | $1.80 | $1.50 |
| Sorpresa | — | +21.5% | -9.4% | +34.7% |
| Métrica | LGND | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | 15.3% | -38.6% | +53.9% |
| Net Margin | 46.4% | -33.6% | +80.0% |
| FCF Margin | 18.2% | -13.9% | +32.1% |
| ROE | 12.2% | -40.4% | +52.6% |
| ROA | 8.0% | -32.0% | +40.0% |
| Current Ratio | 22.23 | 2.84 | +19.39 |
| Debt / Equity | — | 0.28 | — |